Back to search

Article

Biomarkers of Parkinson's Disease: Screening Vital Signs and Routine Blood Tests

2020-05-22

Abstract excerpt

BACKGROUND: There is a need for reliable, objective, and easily accessible biomarkers for Parkinson's disease. OBJECTIVES: The purpose of this study was to screen biomarkers from vital signs and routine blood tests. METHODS: Longitudinal data of up to 7 years of vital signs and routine blood tests from 418 patients with Parkinson's disease (PD) untreated at baseline and 185 individuals without any neurological dis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
05a0c4d6-58d8-56ab-9da0-6f3159bc8c62
DOI
10.1101/2020.05.18.20103085
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Biomarkers of Parkinson's Disease: Screening Vital Signs and Routine Blood TestsDOI 10.1101/2020.05.18.20103085
Diagnostic biomarkers for Parkinson's disease at a glance: where are we?Semantic proximity
Differences in Blood and Cerebrospinal Fluid Between Parkinson’s Disease and Related DiseasesSemantic proximity
Characterization of Parkinson’s disease using blood-based biomarkers: A multicohort proteomic analysisSemantic proximity
Parkinson's disease--the continuing search for biomarkers.Semantic proximity
Parkinson’s Disease: Biomarkers, Treatment, and Risk FactorsSemantic proximity
Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluidSemantic proximity
Biomarkers of Parkinson’s disease: 20 years laterSemantic proximity
Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical featuresSemantic proximity
Cytokines, miRNAs, and Antioxidants as Combined Non-invasive Biomarkers for Parkinson’s DiseaseSemantic proximity
Using ‘omics’ to define pathogenesis and biomarkers of Parkinson’s diseaseSemantic proximity
Identification of potential diagnostic biomarkers for Parkinson's diseaseSemantic proximity
Evaluation of the PREDIGT Score in Discriminating Parkinson Disease from Neurological HealthSemantic proximity
Select a neighboring publication to make it the new centre.